1. Subramanian A, Fong CY, Biswas A, Bongso A. 2015 Jun. Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton’s Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells. PLoS One. 10(6):e0127992. doi: 10.1371/journal.pone.0127992. 26061052.
2. Lin HD, Fong CY, Biswas A, Choolani M, Bongso A. 2014 Aug. Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. Stem Cell Rev. 10(4):573-86. doi: 10.1007/s12015-014-9514-3. 24789672.
3. Fong CY, Biswas A, Subramanian A, Srinivasan A, Choolani M, Bongso A. 2014 May. Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts. J Cell Biochem. 115(5):826-38. doi: 10.1002/jcb.24724. 24265231.
4. Tam K, Cheyyatraviendran S, Venugopal J, Biswas A, Choolani M, Ramakrishna S, Bongso A, Fong CY. 2014 Apr. A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds. J Cell Biochem. 115(4):794-803. doi: 10.1002/jcb.24723. 24265214.
5. Fong CY, Tam K, Cheyyatraivendran S, Gan SU, Gauthaman K, Armugam A, Jeyaseelan K, Choolani M, Biswas A, Bongso A. 2014 Feb. Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. J Cell Biochem. 115(2):290-302. doi: 10.1002/jcb.24661. 24038311.